XT
MRVI icon

XTX Topco’s Maravai LifeSciences MRVI Stock Holding History

XTX Topco’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$491K Buy
173,445
+96,730
+126% +$328K 0.01% 2071
2025
Q4 		$249K Sell
76,715
-35,754
-32% -$120K 0.01% 2227
2025
Q3 		$323K Buy
+112,469
New +$287K 0.02% 1453
2025
Q2 		– Sell
-99,458
Closed -$220K – 2880
2025
Q1 		$220K Buy
99,458
+61,270
+160% +$242K 0.01% 1640
2024
Q4 		$208K Buy
38,188
+14,936
+64% +$96.1K 0.02% 1528
2024
Q3 		$193K Buy
+23,252
New +$201K 0.01% 1457
2024
Q2 		– Sell
-15,117
Closed -$131K – 2249
2024
Q1 		$131K Buy
+15,117
New +$102K 0.02% 1295
2023
Q4 		– Sell
-24,615
Closed -$246K – 1913
2023
Q3 		$246K Buy
+24,615
New +$270K 0.04% 873

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

XTX Topco's MRVI Position: Q1 2026 in Review

XTX Topco increased its Maravai LifeSciences (MRVI) stake by 126% in Q1 2026, buying an estimated $328K and bringing the position to 173,445 shares worth $491K. The position accounts for 0.01% of the portfolio, ranked #2071.

XTX Topco first reported a position in MRVI in Q3 2023 and has held it in 8 quarters since. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • XTX Topco held 173,445 shares of Maravai LifeSciences worth $491K as of Q1 2026.
  • XTX Topco bought 96,730 Maravai LifeSciences shares in Q1 2026, an estimated $328K.
  • Maravai LifeSciences made up 0.01% of XTX Topco's portfolio in Q1 2026, its #2071 holding.
  • XTX Topco first reported a position in Maravai LifeSciences in Q3 2023 and has held it in 8 quarters since.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.